Skip to site content

Liver Disease and Diabetes

Quiz for CE Credit

This quiz consists of multiple choice questions with one correct answer.
Please select one answer for each question, then click the Submit Answers button at the end of the quiz.

1. NAFLD is also known as non-alcoholic fatty liver disease, with the distinction of no evidence of hepatocellular injury such as hepatocyte ballooning or fibrosis.

2. Think NAFLD in almost everyone, as approximately 24-30% of the US population has it.

3. Approximately 45-76% of diabetic and obese populations have NAFLD.

4. NASH is known as non-alcoholic steatohepatitis and includes the presence of inflammation and hepatocyte injury such as hepatocyte ballooning and maybe fibrosis.

5. A goal in screening people for NAFLD is to not only identify NAFLD but also identify who may be at high risk for complications related to NAFLD.

6. Likely predictors of NAFLD include which of the following conditions:

7. Patients with excess caloric consumption leading to obesity and related comorbidities is a leading risk factor for NAFLD.

8. Overweight or obese persons with metabolic syndrome, elevated serum aminotransferase levels, and a negative noninvasive workup for other causes of liver disease are likely to have NASH.

9. Weight loss is the cornerstone of treatment for NAFLD, with a modest weight loss of 7% of body weight likely to show improvement in clinical biochemistry, histologic steatohepatitis, and fibrosis.

10. Managing patients with NAFLD should also include assessment and management of CVD risk factors.